MEOX2 and central nervous system cancer: A few papers have been published to date on the role of MEOX2 in glioblastoma, overall showing its overexpression in all types of glioma vs. healthy brain, a negative correlation of MEOX2 expression with survival, and also an enrichment of its expression in GBM patients who do not respond to radiotherapy [23,24,25].